Literature DB >> 12672635

Fish consumption and breast cancer risk.

Paul Terry1, Thomas E Rohan, Alicja Wolk, Marianne Maehle-Schmidt, Cecilia Magnusson.   

Abstract

The omega-3 fatty acids, especially long-chain eicosapentaenoic acid (20:5n-3) and docosahexaenoic (22:6n-3) contained in "fatty" fish, have consistently been shown to retard the growth of breast cancer in vitro and in animal experiments. In contrast, studies of the association between fish consumption and breast cancer risk in human populations have not consistently shown inverse associations. However, previous studies have not considered the specific types of fish consumed. Using data from a large, nationwide case-control study conducted in Sweden, we examined the association between consumption of fatty and lean fish and breast cancer risk. Odds ratios (OR) and 95% confidence intervals were computed from unconditional logistic regression models. High consumption of fish was weakly associated with reduced breast cancer risk, and the association was not statistically significant. With multivariate adjustment, the OR for women with the highest consumption (> or =3.5 servings/wk) compared with women with the lowest (virtually none) was 0.88 (95% confidence interval = 0.60-1.29, P for trend = 0.15). When type of fish was examined separately, the association was similar for fatty and lean fish.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12672635     DOI: 10.1207/S15327914NC441_1

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  2 in total

1.  Fatty fish and fish omega-3 fatty acid intakes decrease the breast cancer risk: a case-control study.

Authors:  Jeongseon Kim; Sun-Young Lim; Aesun Shin; Mi-Kyung Sung; Jungsil Ro; Han-Sung Kang; Keun Seok Lee; Seok-Won Kim; Eun-Sook Lee
Journal:  BMC Cancer       Date:  2009-06-30       Impact factor: 4.430

2.  Cancer and noncancer mortality among American seafood workers.

Authors:  Eric S Johnson; Mohammed F Faramawi; Macodu Sall; Kyung-Mee Choi
Journal:  J Epidemiol       Date:  2011-04-02       Impact factor: 3.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.